Filing Details
- Accession Number:
- 0001179110-21-000338
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-06 17:04:10
- Reporting Period:
- 2021-01-05
- Accepted Time:
- 2021-01-06 17:04:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 861838 | Idera Pharmaceuticals Inc. | IDRA | Biological Products, (No Disgnostic Substances) (2836) | 043072298 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1556327 | J. John Kirby | C/O Idera Pharmaceuticals, Inc. 505 Eagleview Blvd., Suite 212 Exton PA 19341 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-01-05 | 862 | $3.90 | 35,575 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares of Issuer common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 2,563 Restricted Stock Units ("RSUs") on January 3, 2021. This sale is mandated by the Issuer's election under its 2013 Stock Incentive Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- Of the reported securities beneficially owned, 25,125 shares are represented by unvested RSUs.
Billionaire Hedge Funds
